Get the Stockscreener App
34.38
8.18%
2.60
Pre-market:
33.75
-0.63
-1.83%
Liquidia Corp stock is traded at $34.38, with a volume of 2.04M.
It is up +8.18% in the last 24 hours and down -22.62% over the past month.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
See More
Previous Close:
$31.78
Open:
$32
24h Volume:
2.04M
Relative Volume:
1.17
Market Cap:
$2.99B
Revenue:
$19.32M
Net Income/Loss:
$-141.47M
P/E Ratio:
-20.40
EPS:
-1.6851
Net Cash Flow:
$-120.48M
1W Performance:
+14.60%
1M Performance:
-22.62%
6M Performance:
+19.21%
1Y Performance:
+126.26%
1-Day Range:
$31.66
$34.54
1-Week Range:
$29.12
$34.54
52-Week Range:
$11.26
$46.67
Liquidia Corp Stock (LQDA) Company Profile
Name
Liquidia Corp
Sector
Industry
Phone
919.328.4400
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
34.38 | 2.76B | 19.32M | -141.47M | -120.48M | -1.6851 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Aug-15-25 | Resumed | Jefferies | Buy |
| May-19-25 | Downgrade | Oppenheimer | Perform → Underperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-19-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-16-24 | Initiated | Raymond James | Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Perform |
| Jan-05-24 | Reiterated | Needham | Buy |
| Sep-19-22 | Resumed | Wedbush | Underperform |
| Sep-01-22 | Downgrade | Wedbush | Neutral → Underperform |
| Jul-22-22 | Initiated | Ladenburg Thalmann | Buy |
| May-31-22 | Initiated | BTIG Research | Buy |
| May-26-22 | Initiated | BofA Securities | Buy |
| Dec-04-20 | Initiated | H.C. Wainwright | Buy |
| Nov-20-20 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-08-18 | Resumed | Jefferies | Buy |
| Sep-05-18 | Initiated | Wedbush | Outperform |
| Aug-20-18 | Initiated | Jefferies | Buy |
| Aug-20-18 | Initiated | Needham | Buy |
View All
Liquidia Corp Stock (LQDA) Latest News
Liquidia Corp (LQDA) Trading 4.78% Higher on Mar 4 - GuruFocus
Liquidia (LQDA) Set to Announce Earnings with High Expectations - GuruFocus
LQDA SEC FilingsLiquidia Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
A Peek at Liquidia's Future Earnings - Benzinga
All eyes on Liquidia earnings as biotech eyes profitability - Investing.com
HC Wainwright Predicts Liquidia FY2030 Earnings - MarketBeat
Liquidia (LQDA) General Counsel sells shares to cover RSU taxes - Stock Titan
Liquidia (LQDA) CCO Moomaw sells 827 shares and converts RSUs - Stock Titan
Liquidia (LQDA) CHRO sells 276 shares under 10b5-1 tax transaction - Stock Titan
Liquidia (LQDA) CFO/COO logs small stock sale and RSU conversion - Stock Titan
Liquidia (LQDA) CAO Boyle sells 445 shares to cover RSU taxes - Stock Titan
Liquidia (NASDAQ: LQDA) CBO sells shares to cover RSU taxes - Stock Titan
Liquidia Corp Stock: Why This FDA Drama Has Traders on Edge - AD HOC NEWS
Liquidia Corp. Stock Hits Day Low of $29.20 Amid Price Pressure - Markets Mojo
Liquidia's March 5 Print: Is the YUTREPIA Launch Already Priced In? - Bitget
Liquidia's March 5 Report: Has the YUTREPIA Launch Been Factored Into the Price? - Bitget
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026 - The Manila Times
Biopharma Liquidia plans March 5 webcast on its 2025 year in numbers - Stock Titan
Liquidia (LQDA) Stock Drops 10% After Competitor's New Launch An - GuruFocus
LQDA Stock: Needham Reiterates Buy Rating and Maintains $52 Targ - GuruFocus
GSA Capital Partners LLP Purchases New Shares in Liquidia Corporation $LQDA - MarketBeat
Liquidia stock price rebounds today after Tuesday tumble as options heat up - Bez Kabli
CenterBook Partners LP Decreases Stock Holdings in Liquidia Corporation $LQDA - MarketBeat
Liquidia (NASDAQ:LQDA) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Liquidia Target of Unusually Large Options Trading (NASDAQ:LQDA) - MarketBeat
Liquidia Corporation (LQDA) Gains Momentum Following Overturning of District Court Patent Ruling - Insider Monkey
Is Liquidia Corporation stock influenced by commodity pricesJuly 2025 Price Swings & Weekly Stock Breakout Alerts - mfd.ru
While Liquidia (NASDAQ:LQDA) shareholders have made 991% in 5 years, increasing losses might now be front of mind as stock sheds 9.3% this week - Yahoo Finance
EXEL or LQDA: Which Is the Better Value Stock Right Now? - Yahoo Finance
LQDA April 2nd Options Begin Trading - Nasdaq
[Form 4] Liquidia Corp Insider Trading Activity - Stock Titan
Caprock Group LLC Purchases New Shares in Liquidia Corporation $LQDA - MarketBeat
Liquidia Technologies stock hits 52-week high at 43.0 USD By Investing.com - Investing.com South Africa
Liquidia Technologies stock hits 52-week high at 43.0 USD - Investing.com
Surging Revenue And Technical Momentum Could Be A Game Changer For Liquidia (LQDA) - simplywall.st
Liquidia Corp (NASDAQ:LQDA) Identified as High-Growth Momentum Candidate by Minervini Trend Template - ChartMill
Liquidia (NASDAQ:LQDA) Sets New 52-Week HighHere's Why - MarketBeat
Liquidia Reaches Analyst Target Price - Nasdaq
Liquidia Technologies stock hits all-time high at 43.44 USD - Investing.com
LQDA March 13th Options Begin Trading - Nasdaq
Liquidia (NASDAQ:LQDA) CAO Dana Boyle Sells 1,580 Shares - MarketBeat
Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress - The Manila Times
Liquidia Options Trading: A Deep Dive into Market Sentiment - Benzinga
Inflation Data: What drives Liquidia Corporations stock price2025 Bull vs Bear & Safe Entry Momentum Tips - baoquankhu1.vn
Liquidia (NASDAQ:LQDA) Reaches New 52-Week HighTime to Buy? - MarketBeat
Liquidia Technologies stock hits all-time high at 41.77 USD - Investing.com
Liquidia Corporation (NASDAQ:LQDA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Institution Moves: Does Liquidia Corporation outperform in volatile marketsBear Alert & Stepwise Trade Execution Plans - baoquankhu1.vn
Liquidia Corp and MP Materials See Surge in Options Trading Volume - Intellectia AI
Liquidia Corporation (NASDAQ:LQDA) Short Interest Update - MarketBeat
Liquidia (NASDAQ:LQDA) Rating Lowered to Hold at Wall Street Zen - MarketBeat
Liquidia Corp Stock (LQDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
6.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):